Terumo Corporation Unsponsored ADR (TRUMY)
OTC
Closed
Oct 7, 2026
Day's Range
14.6052 wk Range
12.08Overview - TRUMY - Terumo Corporation Unsponsored ADR
Key Statistics
Valuation
Enterprise Value
921.46M
P/E (Trailing)
‪25.01‬
PEG Ratio
‪0.18‬
Price / Sales (TTM)
‪0.01‬
Price / Book
‪2.05‬
EV / EBITDA
‪0.47‬
Profitability
Profit Margin
‪13.89%‬
Operating Margin
‪28.69%‬
Return on Assets
‪6.92%‬
Return on Equity
‪10.85%‬
Ownership
Shares Outstanding
1.47B
Float
1.44B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.01%‬
Price stats
Beta
‪0.23‬
50-Day Avg
‪15.02‬
200-Day Avg
‪13.98‬
Dividends
Payout Ratio
‪31.61%‬
Frequency
Semi-Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TRUMY - Terumo Corporation Unsponsored ADR
Peers - TRUMY - Terumo Corporation Unsponsored ADR
Peer Comparison
Compared with companies in Medical Devices listed on OTC.
Profile Summary - TRUMY - Terumo Corporation Unsponsored ADR
About
Terumo Corporation Unsponsored ADR represents shares of Terumo Corporation, a Japan-based medical technology company, on the US stock market. The primary function of this asset is to make Terumo's shares accessible to American investors without needing to directly purchase shares on foreign exchanges. Terumo…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
